News
13hon MSN
The FDA has issued warnings regarding potential cardiac risks, specifically myocarditis and pericarditis, associated with the ...
10h
WGAU Athens Radio on MSNFDA expands warning on rare heart risk linked to Pfizer and Moderna COVID vaccinesThe Food and Drug Administration has updated its warning labels for the Pfizer and Moderna COVID-19 vaccines, expanding ...
1d
Stocktwits on MSNModerna, Pfizer, Novavax Draw Bearish Buzz Ahead Of CDC Panel With Vaccine SkepticsRetail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...
Labels for the Pfizer and Moderna shots, which already caution about myocarditis and pericarditis, will more strongly stress ...
The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...
U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...
The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...
RFK Jr. turned the CDC's vaccine committee into an anti-vaccine panel, but it still heard evidence that his campaign against ...
The FDA has expanded warnings for Pfizer and Moderna COVID-19 vaccines regarding the risk of myocarditis, primarily among young men. Although the CDC's data suggested no increased risk, new advisors ...
Pfizer's RSV shot Abrysvo was cleared by the FDA last October for the 18 to 59 age group, extending its 2023 approval in the ...
The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results